Bradley Root, DO
Pain Medicine · St George, UTNPI 1154312197
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for pain medicine clinicians in UT, where the typical reported total is $3,451.
Across 152 payments — averaging $20.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$512
- Boston Scientific$452
- AbbVie$359
- Pfizer$307
- Protega Pharmaceutials Inc$241
- Collegium Pharmaceutical, Inc.$196
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,116100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 22 | $512 |
| Boston Scientific | 18 | $452 |
| AbbVie | 18 | $359 |
| Pfizer | 18 | $307 |
| Protega Pharmaceutials Inc | 12 | $241 |
| Collegium Pharmaceutical, Inc. | 10 | $196 |
| Averitas Pharma Inc. | 7 | $191 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $97 |
| Indivior Inc. | 4 | $96 |
| Amgen(2 entities) | 5 | $83 |
| Saol Therapeutics Inc. | 1 | $74 |
| Teva Pharmaceuticals USA, Inc. | 3 | $70 |
| Idorsia Pharmaceuticals US Inc | 4 | $60 |
| Daiichi Sankyo Inc. | 3 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Medtronic(2 entities) | 3 | $43 |
| Biodelivery Sciences International, Inc. | 3 | $36 |
| GRT US Holding, Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Shionogi Inc | 2 | $25 |
| Relievant Medsystems, Inc. | 2 | $22 |
| Nevro Corp. | 1 | $19 |
| Vertex | 1 | $18 |
| Biogen | 1 | $15 |
| Sentynl Therapeutics, Inc. | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
| Abbott | 1 | $12 |
How this compares
$3,116 in reported general payments places this provider in the 45th percentile of 61 pain medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 220 | $46,939 |
| Oxycodone Hcl | 644 | $22,041 |
| Fentanyl | 95 | $15,960 |
| LyricaPregabalin | 18 | $14,299 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 262 | $12,323 |
| SymproicNaldemedine Tosylate | 23 | $10,480 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 291 | $10,100 |
| Morphine Sulfate ErMorphine Sulfate | 165 | $7,978 |
| BelbucaBuprenorphine Hcl | 11 | $7,692 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 47 | $6,963 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 40 | $5,964 |
| Hydromorphone Hcl | 68 | $4,751 |
| MovantikNaloxegol Oxalate | 11 | $4,485 |
| Pregabalin | 187 | $4,478 |
| Tramadol Hcl ErTramadol Hcl | 50 | $4,228 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerLyrica | $307 | $14,29918 claims |
| Shionogi IncSymproic | $25 | $10,48023 claims |
| Collegium Pharmaceutical, Inc.Belbuca | $196 | $7,69211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 61 pain medicine providers in Utah.
Other pain medicine in St George
- Jon ObraySt George$24K
- Joseph EmpeySt George$8K
- Bryt ChristensenSt George$6K
- Casey MuirSt George$4K
- Stacie OliverSt George$4K
- Dale StottSt George$109
- Maria SchwartzSalt Lake City$813K
- Jeremy JoyalDraper$170K
- Lynn WebsterSalt Lake City$160K
- Benjamin HumpherysLayton$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.